Following abrupt or tapered discontinuation in placebo-controlled clinical trials, the following symptoms occurred at a significantly higher rate in duloxetine-treated patients compared to those discontinuing from placebo: dizziness, nausea, headache, paresthesia, fatigue, vomiting, irritability, insomnia, diarrhea, anxiety, and hyperhidrosis (increased sweating). Search Cymbalta PDR and Eli Lilly
P.S.